Yasuko Onuma
Overview
Explore the profile of Yasuko Onuma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
634
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haramoto Y, Onuma Y, Mawaribuchi S, Nakajima Y, Aiki Y, Higuchi K, et al.
Regen Ther
. 2020 May;
14:306-314.
PMID: 32462059
Introduction: Tumourigenesis attributed to residual undifferentiated cells in a graft is considered to be a significant issue in cell therapy using human pluripotent stem cells. To ensure the safety of...
2.
Mawaribuchi S, Haramoto Y, Tateno H, Onuma Y, Aiki Y, Ito Y
FEBS Open Bio
. 2020 Apr;
10(6):1056-1064.
PMID: 32237061
The recombinant N-terminal domain of BC2L-C lectin (rBC2LCN) is useful for detecting not only human pluripotent stem cells but also some cancers. However, the cancer types and stages that can...
3.
Ninomiya H, Intoh A, Ishimine H, Onuma Y, Ito Y, Michiue T, et al.
Chemosphere
. 2020 Feb;
250:126124.
PMID: 32092576
Toxic compounds from the mother's diet and medication in addition to genetic factors and infection during pregnancy remain risks for various congenital disorders and misbirth. To ensure the safety of...
4.
Bui P, Nishimura K, Mondejar G, Kumar A, Aizawa S, Murano K, et al.
Cell Rep
. 2019 Nov;
29(7):1909-1922.e5.
PMID: 31722206
Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) is accompanied by dramatic changes in epigenetic programs, including silencing of endogenous and exogenous retroviruses. Here, we utilized replication-defective and persistent...
5.
Mawaribuchi S, Onuma Y, Aiki Y, Kuriyama Y, Mutoh M, Fujii G, et al.
Biochem Biophys Res Commun
. 2019 May;
515(1):176-182.
PMID: 31133376
The recombinant lectin rBC2LCN is a useful marker for discriminating the undifferentiated status of human induced or embryonic stem cells. Recently, rBC2LCN has also been used for detecting some cancers...
6.
Tateno H, Hiemori K, Hirayasu K, Sougawa N, Fukuda M, Warashina M, et al.
Regen Ther
. 2018 Oct;
6:1-8.
PMID: 30271833
Human pluripotent stem cells are considered to be ideal cell sources for regenerative medicine, but their clinical and industrial application is hindered by their tumorigenic potential. Previously we have identified...
7.
Montagne K, Onuma Y, Ito Y, Aiki Y, Furukawa K, Ushida T
PLoS One
. 2017 Aug;
12(8):e0183226.
PMID: 28813497
Due to the high water content of cartilage, hydrostatic pressure is likely one of the main physical stimuli sensed by chondrocytes. Whereas, in the physiological range (0 to around 10...
8.
Tateno H, Saito S, Hiemori K, Kiyoi K, Hasehira K, Toyoda M, et al.
Glycobiology
. 2016 Apr;
26(12):1328-1337.
PMID: 27038486
Human somatic stem cells such as human mesenchymal stem cells (hMSCs) are considered attractive cell sources for stem cell-based therapy. However, quality control issues have been raised concerning their safety...
9.
Haramoto Y, Takahashi S, Oshima T, Onuma Y, Ito Y, Asashima M
Sci Rep
. 2015 Jun;
5:11603.
PMID: 26112133
Insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF1R) signalling is required for normal embryonic growth and development. Previous reports indicated that the IGF/IGF1R/MAPK pathway contributes to neural induction and...
10.
Hirabayashi J, Tateno H, Onuma Y, Ito Y
Adv Healthc Mater
. 2015 Apr;
4(16):2520-9.
PMID: 25872477
Human pluripotent stem cells (hPSCs), represented by embryonic stem (hESCs) and induced pluripotent stem cells (hiPSCs), are attracting increasing attention in various research fields. However, their application in a clinical...